Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma
- 1 December 2004
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 95 (3) , 539-545
- https://doi.org/10.1016/j.ygyno.2004.07.056
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Gemcitabine combined with cisplatin as first-line treatment in patients with epithelial ovarian cancer: a phase II studyGynecologic Oncology, 2003
- Phase 2 trial of single-agent gemcitabine in platinum-paclitaxel refractory ovarian cancerGynecologic Oncology, 2003
- Gemcitabine combination chemotherapy of ovarian cancerGynecologic Oncology, 2003
- Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancerAnti-Cancer Drugs, 2002
- A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinomaCancer, 2000
- A Critique of Surgical Cytoreduction in Advanced Ovarian CancerGynecologic Oncology, 2000
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyGynecologic Oncology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958